logo
Frailty Status Predicts Outcomes After Hospital Discharge

Frailty Status Predicts Outcomes After Hospital Discharge

Medscape2 days ago
TOPLINE:
In older hospitalized adults, frailty was associated with discharge to postacute care facilities and a higher risk for readmissions and mortality.
METHODOLOGY:
Researchers conducted a retrospective cohort study to examine whether frailty was associated with the various facilities patients were discharged to and their health outcomes.
The analysis included over 23,000 patients aged 65 years or older (53% women) who were hospitalized for at least 24 hours between 2021 and 2023 at five hospitals within a US-based academic health system.
An electronic health record-based frailty index capturing 54 age-related health deficits was calculated at the most recent outpatient visit before hospitalization. Patients were classified as non-frail, pre-frail, frail, or severely frail.
Overall, 22% of patients were identified as non-frail, 46% as pre-frail, 23% as frail, and 8% as severely frail.
The hospital discharge destinations included home, home with home health services, and skilled nursing facilities (SNFs); health outcomes included rates of hospital readmission and post-discharge mortality.
TAKEAWAY:
Overall, 61% of patients were discharged home, 24% were discharged to SNF, and 15% were discharged home with home health services.
Patients with higher degrees of frailty were more likely to be discharged to SNFs or home healthcare than to home alone (adjusted odds ratio [aOR], 1.20; 95% CI, 1.09-1.33 for frail and aOR, 1.17; 95% CI, 1.03-1.34 for severely frail patients).
Patients with frailty had higher odds of readmission within 90 days of discharge than those without frailty (aOR, 1.91; 95% CI, 1.67-2.20), with odds increasing as the degree of frailty increased; a similar pattern was observed for the risks for mortality within 90 days after discharge.
Discharge to SNFs was associated with significantly higher mortality, with hazard ratios of 5.46 (95% CI, 4.43-6.73) and 2.06 (95% CI, 1.54-2.77) for those discharged home with home health services than those discharged to home alone.
IN PRACTICE:
'Automated frailty assessment at hospital discharge can identify in real time the most vulnerable individuals — severely frail patients discharged to SNF — for pragmatic trials and population health interventions,' the authors wrote. 'Discharge with home health services, particularly for frail patients, may mitigate readmission risk.'
SOURCE:
This study was led by Charles T. Semelka, of the Department of Internal Medicine at the Wake Forest University School of Medicine in Winston-Salem, North Carolina. It was published online on August 6, 2025, in Journal of the American Geriatrics Society.
LIMITATIONS:
Confounding factors, including functional status, caregiver support, illness severity, may have been unaccounted for. The study was conducted in only one healthcare system in the southeastern US. The analyses only included individuals with a frailty score.
DISCLOSURES:
This study received support from the Foundation of Post-Acute and Long-Term Care Medicine and Claude D. Pepper Older Americans Independence Center, Wake Forest School of Medicine. One author reported receiving grants from the funding agencies for activities related to this work and professional effort.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Eating this surprising fruit might be the key to getting a better night's sleep
Eating this surprising fruit might be the key to getting a better night's sleep

Yahoo

time33 minutes ago

  • Yahoo

Eating this surprising fruit might be the key to getting a better night's sleep

Eating one avocado a day might be the key to a better night's sleep. Adults who included the fruit -- and yes, it's a fruit -- in their daily diet over the course of just six months reported better quality sleep compared to people who consumed fewer than two avocados each month, researchers said. 'Sleep is emerging as a key lifestyle factor in heart health, and this study invites us to consider how nutrition — and foods like avocado — can play a role in improving it,' Dr. Kristina Petersen, an associate professor of nutritional sciences at Penn State University, explained. The recent findings on sleep were tied to avocado's beneficial nutrients including tryptophan, folate, and magnesium. An essential mineral, magnesium is involved in muscle contraction and relaxation. Tryptophan and folate are involved in producing melatonin, the hormone that regulates our sleep cycles. These conclusions were drawn following an assessment of 969 U.S. adults who had what is considered a larger waistline -- 35 inches or more in women and 40 inches or more in men. The study was supported by the Avocado Nutrition Center, although the agency had no role in data collection, analysis, or interpretation. The researchers had initially intended to focus on heart health alone, before participants reported sleep-related benefits. "This was a cardiovascular health trial, making the sleep benefits more credible since they emerged as unexpected secondary findings in a well-designed randomized controlled trial," Dr. John Saito, a spokesperson for the American Academy of Sleep Medicine and pulmonologist at Children's Hospital of Orange County, told Verywell this week. Eating avocados daily was also associated with a better diet and lower cholesterol levels, the researchers reported, building on similar research from 2022. Studies have previously found that disrupted sleep is linked to high levels of cholesterol: the waxy, fat-like substance that can lead to heart attack and stroke. Improved heart health can help people to get better sleep, and getting enough sleep can also improve heart health and slash the risk of disease, according to the Centers for Disease Control and Prevention. Avocado's healthy fat and fiber contributed to positive cardiovascular impacts. The healthy fat can also help to reduce cholesterol levels, and lower the risk for potentially life-threatening cardiac events. The fiber is tied to a healthy gut and reduced risk of death from any cause. Adults should consume at least 25 grams of fiber each day, according to Harvard Medical School. Of course, healthy fat is still fat, and avocados are packed with both nutrients and calories. An entire large avocado can add upward of 400 calories to your daily diet, the Cleveland Clinic says. But, the fruits are still considered to be healthy when consumed in moderation like being added to a morning smoothie or a salad at lunch. Half an avocado has more potassium than a banana, the Harvard T.H. Chan School of Public Health said. Humans need potassium to help fend off high blood pressure, which can result in kidney disease, eye damage, coronary artery disease, and other complications, if it's left untreated. While the findings of the new study cannot be generalized to all populations, Petersen noted that heart health is influenced by many factors, such as fitness and genetics. 'This is an encouraging step in expanding the science around avocados and the potential benefits of consumption,' she said.

Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling
Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling

Yahoo

time39 minutes ago

  • Yahoo

Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling

Apple Inc. (NASDAQ:AAPL) will introduce a redesigned Blood Oxygen feature for some Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 users through an iPhone and Apple Watch software update later on Thursday. Users with these models in the U.S. who currently do not have the Blood Oxygen feature will have access to the redesigned Blood Oxygen feature by updating their paired iPhone to iOS 18.6.1 and their Apple Watch to watchOS 11.6.1. Following this update, sensor data from the Blood Oxygen app on Apple Watch will be measured and calculated on the paired iPhone, and results can be viewed in the Respiratory section of the Health app.A recent U.S. Customs ruling enabled this update. There will be no impact on Apple Watch units previously purchased that include the original Blood Oxygen feature, nor will it impact Apple Watch units purchased outside of the U.S. Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 also offer users irregular rhythm notifications, the ECG app, Sleep Apnea Notifications, Fall Detection, sleep tracking, wrist temperature sensing, the Vitals app, the Noise app, the Medications app, and the Mindfulness app, among many other health-related tools. The Verge reported that Apple has been locked in a long-running legal fight with Masimo Corp (NASDAQ:MASI), a medical device company known for its pulse oximeters. MASI stock is trading around 3.4% lower at $150.64 on Thursday. Masimo sued Apple in 2020, accusing it of patent infringement and stealing trade secrets. In 2021, Masimo also brought the case to the U.S. International Trade Commission (ITC), which led to an import ban on certain Apple products in December 2023. Apple has countersued, claiming Masimo's smartwatches copy the Apple Watch, and an appeal against the ITC ban. The appeal is still in progress, while Masimo's patents remain valid until 2028. In another set of events, Apple is planning a major return to the AI race with a range of new products, including robots, an upgraded Siri, a smart speaker with a screen, and home-security cameras. A tabletop robot, expected in 2027, is at the center of the plan and designed to act as a virtual companion. A smart speaker with a built-in display is set to launch next year as part of Apple's move into more affordable smart-home gadgets. Bloomberg reported that the company also sees home security as a growth area, with new cameras forming the core of an Apple security system that can automate household tasks. While Apple is still developing its AI software, executives believe the hardware lineup will be crucial in regaining ground against rivals like Samsung Electronics Co Ltd (OTC:SSNGY) (OTC:SSNHZ) (OTC:SSNLF), Meta Platform Inc (NASDAQ:META). Beyond home devices, Apple is preparing slimmer, redesigned iPhones for release this year. Plans include smart glasses, a foldable phone, a special 20th-anniversary iPhone, and a new version of its headset called N100. The company is also working on a large foldable device that combines MacBook and iPad features. Price Action: AAPL stock is trading lower by 0.89% to $231.26 at last check Thursday. Read Next:Photo by hanohiki via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? MASIMO (MASI): Free Stock Analysis Report This article Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

AbbVie expands North Chicago API production with $195m investment
AbbVie expands North Chicago API production with $195m investment

Yahoo

timean hour ago

  • Yahoo

AbbVie expands North Chicago API production with $195m investment

AbbVie is investing $195m to strengthen domestic active pharmaceutical ingredient (API) production within the US, with the expansion of its manufacturing plant in North Chicago, Illinois. This development is part of a larger commitment by the company to invest more than $10bn in US capital for innovation and critical manufacturing capacity enhancement. The process of API manufacturing involves creating the active components that are essential for the therapeutic effects of medications. AbbVie aims to enhance its chemical synthesis capabilities in the country with this new facility, which will support current and future neuroscience, immunology and oncology medicines' domestic production. AbbVie chairman CEO Robert Michael stated: "Over the next decade, AbbVie will expand production of API, drug product, peptides and medical devices in the US to support future medical breakthroughs. "This is an important step to maintain US leadership in pharmaceutical innovation and deliver next-generation medicines that make a remarkable impact on patients' lives." The construction on the new API facility in North Chicago is set to commence in autumn 2025, with the site fully operational by 2027. This development will enlarge AbbVie's current manufacturing presence in the US. The company creates more than 6,000 jobs across 11 sites and supports many more through its supplier networks. Illinois Governor JB Pritzker stated: 'AbbVie's decision to expand its manufacturing footprint in Illinois is a testament to our state's world-class workforce, infrastructure, cutting-edge research institutions and location that keeps businesses connected to the nation and the world. 'As a global leader in pharmaceuticals, AbbVie's investment in Illinois bolsters our world-class biomanufacturing ecosystem and creates jobs while it innovates next-generation medicines.' In August 2025, Genmab and AbbVie announced that their subcutaneous bispecific antibody, Epkinly (epcoritamab), had met its dual primary endpoints as a second-line combination therapy for relapsed or refractory (r/r) follicular lymphoma (FL). "AbbVie expands North Chicago API production with $195m investment" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store